ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 10,124 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 2.22% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 2,432 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 0.68% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 15,440 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 5.6% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 4,640 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 3.05% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 23,644 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 1.59% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 10,512 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 8.3% of the total position.
      30Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 1,392 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 1.86% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 1,900 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 4.74% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 60,696 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 3.18% of the total position.
      48Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 2,212 shares, the number of shares held decreased 0.51% compared to the previous period and now represents 1.48% of the total position.
      24Comment
      Report
     
     
     
     

    Most Discussed